Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nalfurafine

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Nalfurafine: Patents, clinical trial progress, indications

Nalfurafine is an investigational drug.

There have been 6 clinical trials for Nalfurafine. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2008.

The most common disease conditions in clinical trials are Pruritus, Kidney Failure, Chronic, and Renal Insufficiency. The leading clinical trial sponsors are Toray Industries, Inc, SK Chemicals Co.,Ltd., and Acologix, Inc.

Recent Clinical Trials for Nalfurafine
TRK-820 Study in Subjects on Hemodialysis With or Without Uremic PruritusToray Industries, IncPhase 1
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving HemodialysisToray Industries, IncPhase 2
A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)Acologix, Inc.Phase 3

See all Nalfurafine clinical trials

Clinical Trial Summary for Nalfurafine

Top disease conditions for Nalfurafine
Top clinical trial sponsors for Nalfurafine

See all Nalfurafine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.